EA-230

• Description:

  EA-230 is a synthetic oligopeptide originally derived from beta-human chorionic gonadotropin (beta-hCG) lysates. EA-230 has anti-inflammatory effects and can be used for the research of sepsis[1].

• UNSPSC:

  12352209

• Target:

  GnRH Receptor

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ea-230.html

• Purity:

  99.92

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  CC(C)[C@@H](C(O)=O)NC(CNC([C@H](CCC(N)=O)NC([C@@H](N)C)=O)=O)=O

• Molecular Formula:

  C15H27N5O6

• Molecular Weight:

  373.40

• References & Citations:

  [1]Gueler F, et al. A novel therapy to attenuate acute kidney injury and ischemic allograft damage after allogenic kidney transplantation in mice. PLoS One. 2015 Jan 24;10 (1) :e0115709.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category:

  Peptides

• Clinical Information:

  Phase 2

• CAS Number:

  [503844-09-5]